Press Releases
Keyword Search
05.11.20
OpGen CEO and Chairman of the Board Issue Letters to Stockholders
05.07.20
OpGen Reports First Quarter 2020 Financial Results and Provides Business Update
04.27.20
OpGen to Provide Business Update and Financial Results for the First Quarter 2020
04.21.20
OpGen Subsidiary Curetis GmbH and Karolinska Institutet Collaborate in Study of Bacterial Co-Infections in COVID-19 Pneumonia Patients
04.16.20
OpGen Subsidiary Ares Genetics Demonstrates Feasibility and Potential of Next Generation Sequencing Based Antibiotic Susceptibility Testing in Multi-Center Study
04.14.20
OpGen Announces Preliminary Unaudited Revenue and Cash Position for First Quarter 2020 and Provides Business Update
04.01.20
OpGen and Curetis Successfully Close their Business Combination Transaction
03.30.20
OpGen Announces Shareholder Approval for Business Combination with Curetis
03.24.20
OpGen Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update for OpGen and Curetis Group
03.24.20
OpGen Provides Further Update on Shareholder Proxy Voting in Relation to the Business Combination with Curetis